Advances in multiple myeloma treatment

Improving cancer care access in the Philippines

Understanding smouldering multiple myeloma: Diagnosis and challenges

Understanding POEM syndrome: Diagnosis and treatment challenges

I can’t wait forever: Treatment of smouldering multiple myeloma (SMM)

From diagnosis to dignity: Palliative care in multiple myeloma

Adding durvalumab to neoadjuvant chemotherapy maintains quality of life in resectable NSCLC

Taletrectinib superior to crizotinib in ROS1-positive non-small cell lung cancer

Perioperative durvalumab in addition to neoadjuvant chemotherapy shows positive results in patients with stage IIIa(N2) NSCLC

Pembrolizumab plus cCRT continue to demonstrate antitumour activity in advanced NSCLC

Treatment with BAY 2927088 led to durable responses in patients previously treated HER2-mutant NSCLC

Dermatologic adverse events in the treatment of NSCLC with amivantamab plus lazertinib significantly reduced